98%
921
2 minutes
20
Objective: Determine the rate of occult lymph node metastasis in advanced laryngeal squamous cell carcinoma and identify its predictive factors.
Methods: A retrospective study including 98 patients with laryngeal cancer classified as T3-T4 N0, who underwent bilateral lymph node dissection in sectors II, III and IV.
Result: The median age of our patients was 61. The main symptom was dysphonia (96%). On CT scan, the thyroid cartilage was invaded in 53.5% of cases, and the HTE space in 50% of cases. It was essentially laryngeal squamous cell carcinoma of high grade in 6.1% of cases and of low grade in 93.9% of cases. We found lymph node involvement in 33 lymph node dissections (33.6%) in 24 patients (24.4%) with extranodal extension in 4 cases. Level IIA and III were the most commonly affected, with 28.6% and 21.4% of cases respectively. We noted a vascular emboli and perineural invasion in 5 patients. The predictive factors for MGO in our present study were age over 65, invasion of the subglottic stage, involvement of the thyroid cartilage, the hyo-thyro-epiglottic space, peri-neural invasion and limits of resection.
Conclusion: The criteria for performing lymph node dissection in cases of laryngeal cancer are becoming more restricted for patients with clinically negative lymph nodes (cN0). Nevertheless, for cases of locally advanced tumors, proactive lymph node dissection is advocated, particularly when certain predictive factors for hidden lymph node metastases are present.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297180 | PMC |
http://dx.doi.org/10.1007/s12070-025-05595-1 | DOI Listing |
J Bras Pneumol
September 2025
. Universidade Federal do Rio de Janeiro, Rio de Janeiro (RJ) Brasil.
Anticancer Drugs
September 2025
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Nonsmall cell lung cancer (NSCLC) with SMARCA4 deficiency represents a rare subset of lung tumors characterized by early metastasis, poor response to chemotherapy, and unfavorable prognosis. Established therapy strategies for SMARCA4-deficient NSCLC remain elusive. While immune checkpoint inhibitors have been proposed as a potential solution, their efficacy remains uncertain.
View Article and Find Full Text PDFInt J Surg
September 2025
Guangxi Medical University, Nanning, Guangxi, China.
Ann Nucl Med
September 2025
Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Objective: This study aims to systematically evaluate the inter- and intra-observer agreement regarding lesions with uncertain malignancy potential in Ga-68 PSMA PET/CT imaging of prostate cancer patients, utilizing the PSMA-RADS 2.0 classification system, and to emphasize the malignancy evidence associated with these lesions.
Methods: We retrospectively reviewed Ga-68 PSMA PET/CT images of patients diagnosed with prostate cancer via histopathology between December 2016 and November 2023.
Ann Surg Oncol
September 2025
Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Background: The optimal number of examined lymph nodes (ELN) for accurate staging and prognosis for esophageal cancer patients receiving neoadjuvant therapy remains controversial. This study aimed to evaluate the impact of ELN count on pathologic staging and survival outcomes and to develop a predictive model for lymph node positivity in this patient population.
Methods: Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database and a multicenter cohort.